Strive, Inc. (United States) (ASST)
30.03
-0.08
(-0.27%)
USD |
NASDAQ |
Oct 02, 16:00
30.17
+0.14
(+0.47%)
After-Hours: 20:00
Strive Net Income (Quarterly) : -257.60M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -257.60M |
| March 31, 2026 | -265.91M |
| December 31, 2025 | -201.31M |
| September 30, 2025 | -206.65M |
| June 30, 2025 | -2.665M |
| March 31, 2025 | -1.624M |
| December 31, 2024 | -1.965M |
| September 30, 2024 | -1.315M |
| June 30, 2024 | -1.726M |
| March 31, 2024 | -1.387M |
| December 31, 2023 | -1.348M |
| Date | Value |
|---|---|
| September 30, 2023 | -1.190M |
| June 30, 2023 | -1.321M |
| March 31, 2023 | -1.071M |
| December 31, 2022 | -0.2323M |
| September 30, 2022 | -0.0837M |
| June 30, 2022 | -0.2451M |
| March 31, 2022 | -0.0842M |
| December 31, 2021 | 0.0136M |
| September 30, 2021 | -0.0205M |
| June 30, 2021 | 0.0348M |
| March 31, 2021 | -0.0131M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Daxor Corp. | -- |
| Meridian Holdings, Inc. (California) | 0.0061M |
| Hyperliquid Strategies, Inc. | 470.89M |
| TransMedics Group, Inc. | 14.68M |
| Abbott Laboratories | 928.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.14M |
| Total Expenses (Quarterly) | 257.74M |
| EPS Diluted (Quarterly) | -3.770 |
| Enterprise Value | 2.978B |
| Gross Profit Margin (Quarterly) | -1.02K% |
| Profit Margin (Quarterly) | -184.0K% |
| Earnings Yield | -63.60% |
| Normalized Earnings Yield | -51.70 |